These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

522 related articles for article (PubMed ID: 27757541)

  • 1. Pathologic response grade after long-course neoadjuvant chemoradiation does not influence morbidity in locally advanced mid-low rectal cancer resected by laparoscopy.
    Landi F; Espín E; Rodrigues V; Vallribera F; Martinez A; Charpy C; Brunetti F; Azoulay D; de'Angelis N
    Int J Colorectal Dis; 2017 Feb; 32(2):255-264. PubMed ID: 27757541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncologic outcomes after neoadjuvant chemoradiation followed by curative resection with tumor-specific mesorectal excision for fixed locally advanced rectal cancer: Impact of postirradiated pathologic downstaging on local recurrence and survival.
    Kim NK; Baik SH; Seong JS; Kim H; Roh JK; Lee KY; Sohn SK; Cho CH
    Ann Surg; 2006 Dec; 244(6):1024-30. PubMed ID: 17122629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical outcome of neoadjuvant chemoradiation in locally advanced rectal cancer at a tertiary hospital.
    Yeung WW; Ma BB; Lee JF; Ng SS; Cheung MH; Ho WM; Tsang MW; Chu S; Lam DC; Mo FK
    Hong Kong Med J; 2016 Dec; 22(6):546-55. PubMed ID: 27795447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CEA - a predictor for pathologic complete response after neoadjuvant therapy for rectal cancer.
    Wallin U; Rothenberger D; Lowry A; Luepker R; Mellgren A
    Dis Colon Rectum; 2013 Jul; 56(7):859-68. PubMed ID: 23739192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does pathologic response of rectal cancer influence postoperative morbidity after neoadjuvant radiochemotherapy and total mesorectal excision?
    Maggiori L; Bretagnol F; Aslam MI; Guedj N; Zappa M; Ferron M; Panis Y
    Surgery; 2014 Mar; 155(3):468-75. PubMed ID: 24439750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term oncological outcomes of robotic versus laparoscopic total mesorectal excision of mid-low rectal cancer following neoadjuvant chemoradiation therapy.
    Lim DR; Bae SU; Hur H; Min BS; Baik SH; Lee KY; Kim NK
    Surg Endosc; 2017 Apr; 31(4):1728-1737. PubMed ID: 27631313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant therapy sparing in rectal cancer achieving complete response after chemoradiation.
    García-Albéniz X; Gallego R; Hofheinz RD; Fernández-Esparrach G; Ayuso-Colella JR; Bombí JA; Conill C; Cuatrecasas M; Delgado S; Ginés A; Miquel R; Pagés M; Pineda E; Pereira V; Sosa A; Reig O; Victoria I; Feliz L; María de Lacy A; Castells A; Burkholder I; Hochhaus A; Maurel J
    World J Gastroenterol; 2014 Nov; 20(42):15820-9. PubMed ID: 25400468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term prognostic value of mesorectal grading after neoadjuvant chemoradiotherapy for rectal cancer.
    Madbouly KM; Hussein AM; Abdelzaher E
    Am J Surg; 2014 Sep; 208(3):332-41. PubMed ID: 24581995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is adjuvant chemotherapy necessary for patients with pathological complete response after neoadjuvant chemoradiotherapy and radical surgery in locally advanced rectal cancer? Long-term analysis of 40 ypCR patients at a single center.
    Zhou J; Qiu H; Lin G; Xiao Y; Wu B; Wu W; Sun X; Lu J; Zhang G; Xu L; Liu Y
    Int J Colorectal Dis; 2016 Jun; 31(6):1163-8. PubMed ID: 27044403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statin therapy is associated with improved pathologic response to neoadjuvant chemoradiation in rectal cancer.
    Mace AG; Gantt GA; Skacel M; Pai R; Hammel JP; Kalady MF
    Dis Colon Rectum; 2013 Nov; 56(11):1217-27. PubMed ID: 24104995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laparoscopic total mesorectal excision after neoadjuvant chemoradiotherapy.
    Rosati R; Bona S; Romario UF; Elmore U; Furlan N
    Surg Oncol; 2007 Dec; 16 Suppl 1():S83-9. PubMed ID: 18042378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative Outcomes of Neoadjuvant Treatment Prior to Total Mesorectal Excision and Total Mesorectal Excision Alone in Selected Stage II/III Low and Mid Rectal Cancer.
    Kulu Y; Tarantino I; Billeter AT; Diener MK; Schmidt T; Büchler MW; Ulrich A
    Ann Surg Oncol; 2016 Jan; 23(1):106-13. PubMed ID: 26305025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An interval >7 weeks between neoadjuvant therapy and surgery improves pathologic complete response and disease-free survival in patients with locally advanced rectal cancer.
    Tulchinsky H; Shmueli E; Figer A; Klausner JM; Rabau M
    Ann Surg Oncol; 2008 Oct; 15(10):2661-7. PubMed ID: 18389322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors for local recurrence in patients with rectal cancer submitted to neoadjuvant chemoradiotherapy and total mesorectal excision.
    Nahas CSR; Nahas SC; Marques CFS; Ribeiro Junior U; Bustamante-Lopez L; Cotti GC; Imperiale AR; Pinto RA; Cecconello I
    Clinics (Sao Paulo); 2024; 79():100464. PubMed ID: 39126876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncologic outcomes of neoadjuvant chemoradiation for locally advanced rectal cancer: a single-institution experience.
    Leong YH; Leong CN; Tay GS; Sim R; Lopes G; Low W; Choo BA; Tey J
    Ann Acad Med Singap; 2014 Dec; 43(12):569-75. PubMed ID: 25588915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of interval between neoadjuvant chemoradiotherapy and TME for locally advanced rectal cancer on pathologic response and oncologic outcome.
    Wolthuis AM; Penninckx F; Haustermans K; De Hertogh G; Fieuws S; Van Cutsem E; D'Hoore A
    Ann Surg Oncol; 2012 Sep; 19(9):2833-41. PubMed ID: 22451236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive Significance of Mucinous Histology on Pathologic Complete Response Rate Following Capecitabine-Based Neoadjuvant Chemoradiation in Rectal Cancer: a Comparative Study.
    Hosseini S; Nguyen N; Mohammadianpanah M; Mirzaei S; Bananzadeh AM
    J Gastrointest Cancer; 2019 Dec; 50(4):716-722. PubMed ID: 29984382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is adjuvant chemotherapy really needed after curative surgery for rectal cancer patients who are node-negative after neoadjuvant chemoradiotherapy?
    Kiran RP; Kirat HT; Burgess AN; Nisar PJ; Kalady MF; Lavery IC
    Ann Surg Oncol; 2012 Apr; 19(4):1206-12. PubMed ID: 21935748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognosis factors for recurrence in patients with locally advanced rectal cancer preoperatively treated with chemoradiotherapy and adjuvant chemotherapy.
    Arredondo J; Baixauli J; Beorlegui C; Arbea L; Rodríguez J; Sola JJ; Chopitea A; Hernández-Lizoáin JL
    Dis Colon Rectum; 2013 Apr; 56(4):416-21. PubMed ID: 23478608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical complications and pathologic complete response after neoadjuvant chemoradiation in locally advanced rectal cancer.
    Duldulao MP; Lee W; Le M; Wiatrek R; Nelson RA; Chen Z; Li W; Kim J; Garcia-Aguilar J
    Am Surg; 2011 Oct; 77(10):1281-5. PubMed ID: 22127070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.